Treatment of intestinal worms is associated with decreased HIV plasma viral load

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue 1, 2002, Pages 56-62

  Wolday, Dawit ^a   Mayaan, Shlomo ^a   Mariam, Zeru G ^a   Berhe, Nega ^a   Seboxa, Teshale ^a   Britton, Sven ^a   Galai, Noya ^a   Landay, Alan ^a   Bentwich, Zvi ^a  

^a ROSETTA GENOMICS LTD   (Israel)

Author keywords

Deworming; Helminthic infection; HIV; HIV plasma viral load; Immune activation

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; PRAZIQUANTEL;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ETHIOPIA; FEMALE; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; WORM EGG;

EID: 0036737346     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200209010-00008     Document Type: Article

References (39)

1. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-91.
2. Chan MS. The global burden of intestinal nematode infectionsfifty years on. Parasitol Today 1997;13:438-43.
3. Bundy DA, de Silva NR. Can we deworm this wormy world? Br Med Bull 1998;54:421-32.
4. Dyer JR, Kazembe P, Vernazza PL, et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis 1998;177:1742-6.
5. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997;349:1868-73.
6. Hoffman IF, Jere CS, Taylor TE, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999;13:487-94.
7. Agarwal AK, Singh NY, Devi LB, et al. Clinical features and HIV progression as observed longitudinally in a cohort of injecting drug users in Manipur. Indian J Med Res 1998;108:51-7.
8. Anzala OA, Nagelkerke NJ, Bwayo JJ, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995;171:686-9.
9. Cleghorn FR, Jack N, Edwards J, et al. Rapid time to AIDS in a heterosexual incident cohort in Trinidad and Tobago [abstract TuOrC432]. Presented at the XIII International AIDS Conference, Durban, South Africa, July 2000.
10. Deschamps MM, Fitzgerald DW, Pape JW, et al. HIV infection in Haiti: natural history and disease progression. AIDS 2000;14:2515-21.
11. Mbaga JM, Pallangyo KJ, Bakari M, et al. Survival time of patients with acquired immune deficiency syndrome: experience with 274 patients in Dar-es-Salaam. East Afr Med J 1990;67:95-9.
12. Bentwich Z, Weisman Z, Moroz C, et al. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin Exp Immunol 1996;103:239-43.
13. Bentwich Z, Weisman Z, Grossman Z, et al. Pathogenesis of AIDS in Africa-lessons from the Ethiopian immigrants in Israel. Immunologist 1997;5:211-26.
14. Kalinkovich A, Weisman Z, Greenberg Z, et al. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol 1998;114:414-21.
15. Shapira-Nahor O, Kalinkovich A, Weisman Z, et al. Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS 1998;12:1731-3.
16. Kalinkovich A, Borkow G, Weisman Z, et al. Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors. Clin Immunol 2001;100:107-17.
17. Kalinkovich A, Weisman Z, Leng Q, et al. Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in Africa. J Hum Virol 1999;2:283-9.
18. Weisman Z, Kalinkovich A, Borkow G, et al. Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds. J Acquir Immune Defic Syndr 1999;21:157-63.
19. Galai N, Kalinkovich A, Burstein R, et al. African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel. Lancet 1997;349:180-1.
20. Bentwich Z. Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases? Reply. Parasitol Today 2001;16:312.
21. Jemaneh L. Comparative prevalences of some common intestinal helminth infections in different altitudinal regions in Ethiopia. Ethiop Med J 1998;36:1-8.
22. Fisseha B, Petros B, Mekonnen Y, et al. Diarrhoea-associated parasitic infectious agents in AIDS patients within selected Addis Ababa hospitals. Ethiop J Health Dev 1999;13:169-73.
23. WHO International Collaborating Group for the Study of the WHO Staging System. Proposed "World Health Organization staging system for HIV infection and disease": preliminary testing by an international collaborative cross-sectional study. AIDS 1993;7:711-8.
24. Ebrahim A, El Morshedy H, Omer E, et al. Evaluation of the Kato-Katz thick smear and formol ether sedimentation techniques for quantitative diagnosis of Schistosoma mansoni infection. Am J Trop Med Hyg 1997;57:706-8.
25. Kassa E, Rinke de Wit TF, Hailu E, et al. Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 1999;13:381-9.
26. Messele T, Abdulkadir M, Fontanet AL, et al. Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol 1999;115:443-50.
27. Tsegaye A, Messele T, Tilahun T, et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 1999;6:410-14.
28. Morgan D, Whitworth J. The natural history of HIV-1 infection in Africa. Nat Med 2001;7:143-5.
29. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9.
30. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
31. Karanja DM, Colley DG, Nahlen BL, et al. Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 1997;56:515-21.
32. Doenhoff MJ. Granulomatous inflammation and the transmission of infection: schistosomiasis and TB too? Immunol Today 1998;19:462-7.
33. Bentwich Z, Kalinkovich A, Weisman Z, et al. Can eradication of helminthic infections change the face of AIDS and tuberculosis? Immunol Today 1999;20:485-7.
34. Wolday D, Berhe N, Akuffo H, et al. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today 1999;15:182-7.
35. Berhe N, Wolday D, Hailu A, et al. HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS 1999;13:1921-5.
36. Bentwich Z, Maartens G, Torten D, et al. Concurrent infections and HIV pathogenesis. AIDS 2000;14:2071-81.
37. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271-8.
38. Borkow G, Leng Q, Weisman Z, et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 2000;106:1053-60.
39. Lawn SD, Karanja DM, Mwinzia P, et al. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS 2000;14:2437-43.